Canada: Politicians Reassured Over HIV

16 June 1996

Past Canadian federal and provincial health ministers have been assured that they personally have nothing to fear from Judge Horace Krever's Commission of Inquiry into the Blood System in Canada, which is investigating the contaminated blood products scandal (Marketletter April 29).

Last December 21, 45 notices naming 95 people, government organizations, the Red Cross and four drugmakers (Armour, Baxter Corp, Bayer Inc and Connaught Labs) were issued with notices by the Commission under Section 13 of the Federal Inquiries Act, which states that any person or organization must be informed in advance if they are to be named in "allegations of potential misconduct" in the Commission's final report.

80 of these people and groups are opposing the notices, saying that if misconduct is assigned to them they could face criminal charges and destruction of their reputations. In fact, the notices cannot be used in civil or criminal courts, but Connaught Labs lawyer Stephen Goudge said the findings could be "tantamount to criminal or civil liability," adding that royal commissions are not supposed to be trials.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight